Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
Article in The Lancet Oncology (May 2024)
The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.
Article in The Lancet Oncology (May 2024)
Article in Supportive Care in Cancer (February 2023)
Preprint in Research Square (September 2022)